These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2552655)

  • 1. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
    Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
    Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.
    Pliaka V; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonika C; Levidiotou-Stefanou S; Krikelis A; Markoulatos P
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1513-23. PubMed ID: 20820837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
    Georgopoulou A; Markoulatos P
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
    Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
    J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
    Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
    Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth kinetic analysis of bi-recombinant poliovirus vaccine strains.
    Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadi G; Tsakogiannis D; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Virus Genes; 2010 Apr; 40(2):200-11. PubMed ID: 20091423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral poliovirus vaccine in the United States: molecular characterization of Sabin type 3 after replication in the gut of vaccinees.
    Tatem JM; Weeks-Levy C; Mento SJ; DiMichele SJ; Georgiu A; Waterfield WF; Sheip B; Costalas C; Davies T; Ritchey MB
    J Med Virol; 1991 Oct; 35(2):101-9. PubMed ID: 1662701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
    Otelea D; Guillot S; Furione M; Combiescu AA; Balanant J; Candrea A; Crainic R
    Dev Biol Stand; 1993; 78():33-8. PubMed ID: 8099049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].
    Kutitova OK; Lipskaia GIu; Maslova SV; Agol VI
    Mol Gen Mikrobiol Virusol; 1989 Nov; (11):14-20. PubMed ID: 2560812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications.
    Muzychenko AR; Lipskaya GYu ; Maslova SV; Svitkin YV; Pilipenko EV; Nottay BK; Kew OM; Agol VI
    Virus Res; 1991 Oct; 21(2):111-22. PubMed ID: 1661980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
    Cann AJ; Stanway G; Hughes PJ; Minor PD; Evans DM; Schild GC; Almond JW
    Nucleic Acids Res; 1984 Oct; 12(20):7787-92. PubMed ID: 6093054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.
    Georgescu MM; Tardy-Panit M; Guillot S; Crainic R; Delpeyroux F
    J Virol; 1995 Sep; 69(9):5278-86. PubMed ID: 7636970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
    Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction.
    Guillot S; Otelea D; Delpeyroux F; Crainic R
    Vaccine; 1994 May; 12(6):503-7. PubMed ID: 8036823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
    Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
    Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains.
    Martín J; Minor PD
    J Virol; 2002 Jun; 76(11):5339-49. PubMed ID: 11991962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.